Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-16

Clinical Trial Update: Treatment With Rosuvastatin Versus Switching PI (Protease Inhibitor) in Patients HIV With High Cholesterol Levels [Phase 4]

View source ↗

Summary

Phase 4 trial comparing rosuvastatin to switching protease inhibitors in people with HIV and high cholesterol; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Protease inhibitor switch
  • Rosuvastatin (rosuvastatin)

Snippet

Sponsor: Juan A. Arnaiz | Conditions: HIV, Hypercholesterolaemia | Phase 4 | Status: COMPLETED | Results posted: 2025-07-16